Everus Construction Group 株価情報 (NYSE: ECG)

最新ニュース Everus Construction Group (NYSE:ECG) 株価情報

EVERUS CONSTRUCTION GROUP

Everus Construction Group

Everus Construction Group Inc is a construction solutions provider, offering specialty contracting services to a diverse set of end markets across the U.S. It operates across two segments Electrical & Mechanical (E&M) and Transmission & Distribution (T&D), and delivers services through its subsidiaries. It generates the majority of revenue from the Electrical & Mechanical segment which offers a wide variety of specialty contracting services, including construction and maintenance of electrical and communication wiring, fire suppression systems, and mechanical piping and services, to customers in both the public and private sectors. Its T&D segment serves electric and natural gas utility customers, as well as customers in the transportation end market, in the West and Midwest regions.

Everus Construction Group, Inc. Common Stock

Everus Construction Group Inc

Ecograf Ltd

ECGI Holdings Inc

ENVIT CAPITAL GROUP INC by Envit Capital Group, Inc.

Envit Capital Group Inc

Kinetic Seas Inc

Bellatora Inc

ECO-GROWTH STRATEGIES INC by Eco-Growth Strategies Inc.

Eco-Growth Strategies Inc

<ul>
<li>Company unveils a strategic initiative to build the world's first known foundation model for human motion in physical rehabilitation</li>
<li>Collaboration represents an important step toward integrating powerful new AI capabilities into Ekso Bionics' proprietary exoskeleton technology platforms</li>
</ul>

News

Health Care

General

EKSO

NVDA

Ekso Bionics Announced Its Acceptance Into The NVIDIA Connect Program

Earlier this week, the "Shark Tank" investor and entrepreneur, Kevin O'Leary, fondly known as "Mr Wonderful," shared a no-nonsense tactic he swears by to avoid overpaying for services like cable, subscriptions and phone plans.
What Happened: "Every time a bill goes up, I call," O'Leary said in a post on social media. "Not customer service—retention. That's where the real deals are. I negotiate like it's sport. I've been doing it for decades, and I never pay retail."
In the video he shared along with the post, O'Leary noted that retention reps have the power to offer you special, lower-cost plans or promotional discounts to keep you from cancelling. Regular customer-service agents usually can't.
See Also: <a href="https://www.benzinga.com/news/25/03/44433124/mark-cuban-breaks-down-the-no-1-red-flag-that-makes-him-want-to-look-for-a-way-out-on-shark-tank-rev">Mark Cuban Breaks Down The No. 1 Red Flag That Makes Him Want To Look For A Way Out On Shark Tank — Reveals Dumbest Pitches He&#8217;s Seen, From Tail Lightz To Original Man Candle</a>
"Subscription fees, cable bills, you name it—I fight them all. Keeps me sharp. If you're not negotiating your bills, you're just giving money away. And I don't do charity for telecoms," he stated.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Every time a bill goes up, I call. Not customer service—retention. That's where the real deals are. I negotiate like it's sport. I've been doing it for decades, and I never pay retail. Subscription fees, cable bills, you name it—I fight them all. Keeps me sharp. If you're not… <a href="https://t.co/isfHeUtxAT">pic.twitter.com/isfHeUtxAT</a>
&mdash; Kevin O&#39;Leary aka Mr. Wonderful (@kevinolearytv) <a href="https://twitter.com/kevinolearytv/status/1922275638603567490?ref_src=twsrc%5Etfw">May 13, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Earlier this year, in January, streaming giant Netflix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) raised the price of its standard <a href="https://www.benzinga.com/markets/equities/25/01/43119464/netflix-raises-prices-16-peter-schiff-warns-of-escalating-inflation-risks-ahead-of-trump-policies">streaming plan by 16%</a>. In 2022, Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) made a similar move <a href="https://www.benzinga.com/general/entertainment/22/03/26311326/amazon-prime-membership-now-costs-16-more-heres-what-youre-paying-today">and increased the price</a> for Prime customers by 16%.
In July 2023, YouTube Premium, a subsidiary of Alphabet Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google, <a href="https://www.benzinga.com/news/23/07/33297507/youtube-premium-has-got-more-expensive-for-you-now-shell-out-13-99-monthly">raised its monthly price from</a> $11.99 to $13.99 and its annual plan from $119.99 to $139.99—marking its first price increase since launching in 2018.
Similarly, according to a 2022 <a href="https://cordcutting.com/research/paying-for-channels-you-dont-watch/">report</a> by CordCutting.com, the average cost of a cable bill surged from $96 to $147 per month between 2019 and 2022—an increase of 52%. This jump comes even as the number of channels included in standard packages declined, driving the cost per channel from $0.50 to $0.77.&nbsp;
Why It's Important: Accordingly <a href="https://www.celebritynetworth.com/richest-businessmen/ceos/kevin-oleary-net-worth/">to</a> celebrity net worth, Mr Wonderful currently has a net worth of around $400 million.&nbsp;
Born in Montreal in 1954 to Lebanese and Irish parents, O'Leary's early life was shaped by international travel due to his stepfather's work with the United Nations.
Though he once dreamed of becoming a photographer, O'Leary pursued business on his stepfather's advice—earning a degree from the University of Waterloo in 1977 and a Master of Business Administration from Western's Ivey Business School in 1980.
While at Nabisco, he honed marketing skills he later used to co-found SoftKey, an educational software company that bought The Learning Company and was sold to Mattel for $4.2 billion in 1999.
Since then, O'Leary has co-founded storage firms, launched his own wine label and invested in numerous companies through "Shark Tank."
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Image Via Shutterstock
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/03/44219627/mark-cuban-dismisses-commerce-secretary-howard-lutnicks-trade-war-optimism-someone-needs-to-explain-how-capitalism-works" target="_blank" rel="noreferrer noopener">Mark Cuban Dismisses Commerce Secretary Howard Lutnick&#8217;s Trade War Optimism: ‘Someone Needs To Explain…How Capitalism Works&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

Tech

AMZN

GOOG

GOOGL

NFLX

Mr Wonderful Kevin O'Leary Says You're Literally Giving Away Money To Billers By Not Doing This One Simple Thing — And He's Been Doing It For Decades

Earnings

Earnings Misses

DGXX

Digi Power X Q1 Sales $9.30M Miss $12.10M Estimate

WIIM

New Fortress Energy shares are trading lower after the company reported a Q1 sales miss.

NWTG

Newton Golf Q1 EPS $(0.55) Up From $(0.80) YoY, Sales $1.21M Up From $350.00K YoY

HC Wainwright &amp; Co. analyst Matthew Kelsey assumes Acurx Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACXP#NASDAQ">ACXP</a>) with a Buy rating and announces Price Target of $8.

Price Target

Initiation

Analyst Ratings

ACXP

HC Wainwright & Co. Assumes Acurx Pharmaceuticals at Buy, Announces Price Target of $8

SBC Medical Group Holding Q1 EPS $0.21 Up From $0.20 YoY, Sales $47.33M Down From $54.81M YoY

Moving iMage Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MITQ#AMEX">MITQ</a>) reported quarterly losses of $(0.02) per share. This is a 66.67 percent increase over losses of $(0.06) per share from the same period last year. The company reported $3.57 million in sales this quarter. This is a 8.20 percent decrease over sales of $3.89 million the same period last year.

MITQ

Moving iMage Technologies Q3 EPS $(0.02) Up From $(0.06) YoY, Sales $3.57M Down From $3.89M YoY

Needham analyst Mike Cikos reiterates CoreWeave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) with a Buy and maintains $55 price target.

Reiteration

CRWV

Needham Reiterates Buy on CoreWeave, Maintains $55 Price Target

Rosenblatt analyst Barton Crockett maintains Nexxen International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXN#NASDAQ">NEXN</a>) with a Buy and raises the price target from $15 to $16.

NEXN

Rosenblatt Maintains Buy on Nexxen International, Raises Price Target to $16

PENN

PENN Entertainment Sends Letter to Shareholders; Says PENN Play Loyalty Member Base Has Grown 10% YoY And Says Expects To Accelerate Return Of Capital To Shareholders In The Second Half Of The Year And Repurchase At Least $350M Of Common Stock In Calendar 2025

Foot Locker shares are trading higher after DICK's Sporting Goods agreed to acquire the company. Also, the company issued preliminary Q1 Non-GAAP EPS results.

Earnings Beats

ABEO

Abeona Therapeutics Q1 EPS $(0.24) Beats $(0.36) Estimate

Rosenblatt analyst Mike Genovese maintains Cisco Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) with a Buy and raises the price target from $63 to $74.

CSCO

Rosenblatt Maintains Buy on Cisco Systems, Raises Price Target to $74

HC Wainwright &amp; Co. analyst Yi Chen maintains Sanara MedTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTI#NASDAQ">SMTI</a>) with a Buy and raises the price target from $51 to $53.

SMTI

HC Wainwright & Co. Maintains Buy on Sanara MedTech, Raises Price Target to $53

N2OFF to take part in financing a 35MW/140MWh planned Battery Energy Storage System project in Poland
Neve Yarak, Israel, May 15, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc.(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NITO#NASDAQ">NITO</a>) (FSE:80W) ("N2OFF" and the "Company"), a clean tech company engaged in sustainable solutions for energy and innovation for agri- tech, recently announced its entry into the Polish renewable energy market by participating in the financing of a Battery Energy Storage System (BESS) project in Poland.
The project, currently planned at 35MW/140MWh, represents a significant step in expanding Solterra's large-scale energy storage solutions in the region. N2OFF, along with other lenders, will assist with financing an initial payment under a signed grid connection agreement. Future development plans include applying for an increase in capacity to more than 100MW/400MWh.

NITO

N2OFF Enters Into Polish Renewable Energy Market By Participating In Financing Of Battery Energy Storage System Project In Poland

BHVN

Biohaven shares are trading lower after the FDA's Office of Neuroscience extended the PDUFA date for the troriluzole new drug application for the treatment of spinocerebellar ataxia by three months to provide time for a full review of the company's recent submissions related to information requests from the agency.

FTLF

FitLife Brands Q1 EPS $0.20 Misses $0.29 Estimate, Sales $15.94M Beat $15.77M Estimate

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cadrenal.com%2F&amp;esheet=54255465&amp;newsitemid=20250515408603&amp;lan=en-US&amp;anchor=Cadrenal+Therapeutics%2C+Inc.&amp;index=1&amp;md5=eb57e3bf892902967f302bae6cefbdca">Cadrenal Therapeutics, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVKD#NASDAQ">CVKD</a>), a biopharmaceutical company developing therapeutics for patients with cardiovascular disease, today announced manufacturing and supply chain milestones for its lead drug candidate, tecarfarin, a novel oral vitamin K antagonist (VKA) anticoagulant that is designed to address unmet needs in anticoagulation therapy.
Cadrenal completed the technical transfer and manufacturing of its tecarfarin drug substance in accordance with current good manufacturing practices (cGMP) earlier this year at a U.S. site of a leading global Contract Development and Manufacturing Organization (CDMO). Manufacturing of the tecarfarin drug product candidate is currently underway.

CVKD

Cadrenal Therapeutics Announces Manufacturing And Supply Chain Milestones For Tecarfarin, Oral VKA Anticoagulant Designed To Address Unmet Needs In Anticoagulation Therapy

Needham analyst Ryan Koontz reiterates Arista Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) with a Buy and maintains $130 price target.

ANET

Needham Reiterates Buy on Arista Networks, Maintains $130 Price Target

Legal

Press Releases

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Everus Construction Lawsuit – ECG

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Everus Construction Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - ECG

Levi & Korsinsky Reminds Everus Construction Group, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025 - ECG

Deadline Alert: Everus Construction Group, Inc. (ECG) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

Investors who lost money on Everus Construction Group, Inc. (ECG) should contact Levi & Korsinsky about pending Class Action - ECG

Everus Reports First Quarter Results, Affirms Guidance for 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Everus

ECG Investors Have Opportunity to Lead Everus Construction Group, Inc. Securities Fraud Lawsuit

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Canopy Growth, Viatris, Everus, and Cerevel and Encourages Investors to Contact the Firm

Everus Construction Group, Inc. Class Action: The Gross Law Firm Reminds Everus Construction  Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025 - ECG

VTRS

Arcosa

AECOM

Argan

Ameresco

APi Group

Bowman Consulting Group Ltd. - Common Stock

Bowman Consulting Group

Cadeler A/S American Depositary Share (each representing four (4) Ordinary Shares)

Comments

Everus Construction Group

ニュース

最新ニュース Everus Construction Group (NYSE:ECG) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル